Successful treatment of serpiginous choroiditis with alkylating agents (Q44086806)

29 November 2017

title

Successful treatment of serpiginous choroiditis with alkylating agents (English)

1 reference

29 November 2017

main subject

serpiginous choroiditis

1 reference

inferred from title

author name string

Esen Karamursel Akpek

1

1 reference

29 November 2017

Douglas A Jabs

2

1 reference

29 November 2017

Howard H Tessler

3

1 reference

29 November 2017

Brian C Joondeph

4

1 reference

29 November 2017

C Stephen Foster

5

1 reference

29 November 2017

publication date

1 August 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

109

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

1506-1513

1 reference

CHOROIDAL ANGIO-SCLEROSIS WITH SPECIAL REFERENCE TO ITS HEREDITARY CHARACTER.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

A curious affection of the fundus oculi: helicoid peripapillar chorioretinal degeneration. Its relation to pigmentary paravenous chorioretinal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Serpiginous (geographic) choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Geographical choroidopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Cyclosporine-A in the treatment of serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Long-term immunosuppressive treatment of serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

A follow-up study on serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Subretinal and disc neovascularisation in serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Unusual findings in serpiginous choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Triple Agent Immunosuppression in Serpiginous Choroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

CYTOLOGICAL STUDY OF THE EFFECT OF CYCLOPHOSPHAMIDE ON THE EPITHELIUM OF THE URINARY BLADDER IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Treatment of Behçet's disease with chlorambucil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Long-lasting remission of Behcet's disease after chlorambucil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Herpes zoster in patients with treated Wegener's granulomatosis. A possible role for cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Second malignant neoplasms associated with immunosuppressive medications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Effects of cyclophosphamide on the development of malignancy and on long‐term survival of patients with rheumatoid arthritis a 20‐year followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901097-7

7 January 2021

10.1016/S0161-6420(02)01097-7

Identifiers

DOI

1 reference

29 November 2017

1 reference